U.S. Pharmaceutical Sales - Q4 2012
The following is a list of the top 100 prescribed medicines by US National Sales in Q4 2012. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q4 2012 by units sold
| Rank |
Drug |
Units (000) |
|
|
1 ( 1) |
budesonide
Generic |
12,370 |
60.17% |
Stats |
2 ( 1) |
acetaminophen/hydrocodone
Generic |
10,325 |
5.35% |
Stats |
| 3 |
ProAir HFA
Teva Pharmaceuticals USA, Inc. |
7,656 |
5.06% |
Stats |
| 4 (1) |
Nexium
AstraZeneca |
6,836 |
2.01% |
Stats |
| 5 (1) |
Cymbalta
|
6,641 |
4.07% |
Stats |
| 6 (1) |
Lantus
Sanofi |
6,376 |
5.69% |
Stats |
| 7 (3) |
OneTouch
|
6,153 |
-9.58% |
Stats |
| 8 (1) |
atorvastatin
Generic |
6,101 |
10.31% |
Stats |
9 ( ) |
Ventolin HFA
GlaxoSmithKline |
5,987 |
n/a |
Stats |
| 10 (2) |
Advair Diskus
GlaxoSmithKline |
5,853 |
1.56% |
Stats |
| 11 (1) |
Lantus Solostar
Sanofi |
4,668 |
4.48% |
Stats |
| 12 |
fentanyl
Generic |
4,367 |
8.09% |
Stats |
| 13 |
enoxaparin
Generic |
4,350 |
16.37% |
Stats |
| 14 (3) |
Crestor
AstraZeneca |
4,230 |
0.88% |
Stats |
| 15 (1) |
Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc. |
3,664 |
5.56% |
Stats |
| 16 |
Novolog
Novo Nordisk |
3,379 |
8.54% |
Stats |
| 17 |
Levemir
Novo Nordisk |
3,191 |
7.91% |
Stats |
| 18 |
NovoLog FlexPen
Novo Nordisk |
3,025 |
10.32% |
Stats |
| 19 (4) |
AndroGel
AbbVie Inc. |
2,817 |
-15.96% |
Stats |
| 20 |
Humalog
Eli Lilly and Company |
2,633 |
3.17% |
Stats |
| 21 |
Abilify
Otsuka Pharmaceutical Co., Ltd |
2,632 |
4.65% |
Stats |
| 22 (1) |
Nasonex
Merck |
2,545 |
3.12% |
Stats |
| 23 () |
Tamiflu
|
2,516 |
n/a |
Stats |
| 24 |
Synthroid
AbbVie Inc. |
2,454 |
-0.04% |
Stats |
| 25 (3) |
metoprolol
Generic |
2,452 |
-1.25% |
Stats |
| 26 (1) |
Januvia
Merck |
2,369 |
1.89% |
Stats |
| 27 (1) |
Symbicort
AstraZeneca |
2,313 |
12.94% |
Stats |
| 28 (1) |
Namenda
|
2,085 |
-0.10% |
Stats |
| 29 |
Lyrica
|
2,068 |
2.17% |
Stats |
| 30 |
Suboxone
|
2,054 |
2.65% |
Stats |
| 31 |
Zetia
Merck |
1,978 |
1.33% |
Stats |
| 32 (2) |
Flovent HFA
GlaxoSmithKline |
1,962 |
12.95% |
Stats |
| 33 (1) |
Diovan
Novartis Pharmaceuticals Corporation |
1,890 |
-2.88% |
Stats |
| 34 (1) |
Combivent
Boehringer Ingelheim Pharmaceuticals, Inc. |
1,799 |
-6.69% |
Stats |
| 35 |
Lidoderm
Endo Pharmaceuticals Inc. |
1,741 |
4.94% |
Stats |
| 36 |
Lovaza
GlaxoSmithKline |
1,641 |
-0.42% |
Stats |
| 37 |
Remicade
Janssen Pharmaceuticals, Inc. |
1,551 |
-4.32% |
Stats |
| 38 (1) |
Restasis
Allergan plc |
1,546 |
7.21% |
Stats |
| 39 (1) |
Benicar
Daiichi Sankyo |
1,503 |
2.31% |
Stats |
| 40 |
Dexilant
Takeda Pharmaceutical Company Limited |
1,493 |
4.55% |
Stats |
| 41 () |
pioglitazone
Generic |
1,436 |
n/a |
Stats |
| 42 () |
fenofibrate
Generic |
1,283 |
n/a |
Stats |
| 43 (1) |
OxyContin
Purdue Pharma LP |
1,244 |
-0.72% |
Stats |
| 44 (1) |
Vytorin
Merck |
1,117 |
-5.02% |
Stats |
| 45 (1) |
VESIcare
Astellas Pharma US, Inc. |
1,062 |
2.41% |
Stats |
| 46 (1) |
Celebrex
|
1,061 |
2.41% |
Stats |
| 47 (1) |
Enbrel
Amgen Inc. |
1,040 |
4.52% |
Stats |
| 48 (2) |
Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc. |
985 |
-4.18% |
Stats |
| 49 |
Janumet
Merck |
977 |
-0.61% |
Stats |
| 50 (3) |
Niaspan
AbbVie Inc. |
942 |
-6.36% |
Stats |
| 51 (1) |
Evista
|
917 |
-3.07% |
Stats |
| 52 (5) |
methylphenidate
Generic |
842 |
17.76% |
Stats |
| 53 () |
valsartan
Generic |
842 |
n/a |
Stats |
| 54 (1) |
Vyvanse
Takeda Pharmaceutical Company Limited |
837 |
11.75% |
Stats |
| 55 (1) |
Cialis
Eli Lilly and Company |
818 |
9.07% |
Stats |
| 56 (2) |
amphetamine/dextroamphetamine
Generic |
765 |
11.84% |
Stats |
| 57 (1) |
Aciphex
Eisai Inc. |
729 |
-1.88% |
Stats |
| 58 (1) |
Humira
AbbVie Inc. |
669 |
4.53% |
Stats |
| 59 (1) |
Rebif
EMD Serono, Inc. |
612 |
-3.92% |
Stats |
| 60 (1) |
Epogen
Amgen Inc. |
606 |
-0.16% |
Stats |
| 61 (1) |
Truvada
Gilead Sciences, Inc. |
599 |
3.81% |
Stats |
| 62 (2) |
Victoza
Novo Nordisk |
553 |
7.17% |
Stats |
| 63 |
Rituxan
Genentech, Inc. |
550 |
-1.26% |
Stats |
| 64 (4) |
Viagra
|
505 |
10.99% |
Stats |
| 65 (12) |
TriCor
AbbVie Inc. |
504 |
-40.78% |
Stats |
| 66 |
Atripla
Gilead Sciences, Inc. |
483 |
1.68% |
Stats |
| 67 |
Avastin
Genentech, Inc. |
462 |
-2.12% |
Stats |
| 68 (1) |
Seroquel XR
AstraZeneca |
426 |
-0.93% |
Stats |
| 69 (1) |
modafinil
Generic |
398 |
0.76% |
Stats |
| 70 (6) |
Renvela
Sanofi |
359 |
13.61% |
Stats |
| 71 (1) |
Lunesta
Sunovion Pharmaceuticals Inc. |
345 |
0.88% |
Stats |
| 72 (2) |
Adderall XR
Takeda Pharmaceutical Company Limited |
337 |
1.20% |
Stats |
| 73 |
Orencia
Bristol-Myers Squibb Company |
328 |
-2.09% |
Stats |
| 74 (3) |
Sensipar
Amgen Inc. |
325 |
6.21% |
Stats |
| 75 |
Neulasta
Amgen Inc. |
316 |
-4.53% |
Stats |
| 76 () |
Focalin XR
Novartis Pharmaceuticals Corporation |
307 |
n/a |
Stats |
| 77 (2) |
Procrit
Janssen Pharmaceuticals, Inc. |
279 |
-4.45% |
Stats |
| 78 |
Xolair
|
278 |
-4.79% |
Stats |
| 79 (1) |
Reyataz
Bristol-Myers Squibb Company |
277 |
0.36% |
Stats |
| 80 (2) |
Isentress
Merck |
270 |
3.45% |
Stats |
| 81 |
Aranesp
Amgen Inc. |
259 |
-4.78% |
Stats |
| 82 (1) |
Copaxone
Teva Pharmaceuticals USA, Inc. |
249 |
0.81% |
Stats |
| 83 (2) |
Prezista
Janssen Pharmaceuticals, Inc. |
246 |
11.31% |
Stats |
| 84 (2) |
Lucentis
Genentech, Inc. |
228 |
7.04% |
Stats |
| 85 (2) |
Zostavax
Merck |
223 |
10.95% |
Stats |
| 86 (2) |
Alimta
Eli Lilly and Company |
198 |
8.79% |
Stats |
| 87 (4) |
Prevnar 13
Pfizer Inc. |
179 |
13.29% |
Stats |
| 88 (1) |
Neupogen
Amgen Inc. |
170 |
-3.95% |
Stats |
| 89 () |
Synagis
MedImmune, Inc. |
165 |
n/a |
Stats |
| 90 |
Herceptin
Genentech, Inc. |
164 |
1.23% |
Stats |
| 91 (1) |
Zyvox
Pfizer Inc. |
127 |
-1.55% |
Stats |
| 92 () |
Xgeva
Amgen Inc. |
116 |
n/a |
Stats |
| 93 (1) |
Avonex
Biogen Inc. |
112 |
-8.94% |
Stats |
| 94 (1) |
Gleevec
Novartis Pharmaceuticals Corporation |
87 |
-5.43% |
Stats |
| 95 (1) |
Xeloda
Genentech, Inc. |
65 |
n/a |
Stats |
| 96 () |
Sandostatin LAR Depot
Novartis Pharmaceuticals Corporation |
62 |
n/a |
Stats |
| 97 |
Betaseron
Bayer HealthCare Pharmaceuticals Inc. |
61 |
-3.17% |
Stats |
| 98 |
Gilenya
Novartis Pharmaceuticals Corporation |
57 |
3.64% |
Stats |
| 99 |
Stelara
Janssen Pharmaceuticals, Inc. |
23 |
4.55% |
Stats |
| 100 |
Incivek
Vertex Pharmaceuticals Incorporated |
16 |
-11.11% |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
